Last quarter (Q4 2023), Novo Nordisk's total revenue was kr65.86B, an increase of 59.61% from the same quarter last year. In Q4, Novo Nordisk's net income was kr21.96B. See Novo Nordisk’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	kr 164.80B	kr 232.26B	kr 176.95B	kr 140.80B	kr 126.95B	kr 122.02B
Cost of Revenue	kr 25.40B	kr 35.77B	kr 28.45B	kr 23.66B	kr 20.93B	kr 20.09B
Gross Profit	kr 139.40B	kr 196.50B	kr 148.51B	kr 117.14B	kr 106.01B	kr 101.93B
Operating Expense	kr 67.48B	kr 94.04B	kr 74.73B	kr 58.50B	kr 51.89B	kr 49.45B
Operating Income	kr 71.92B	kr 102.45B	kr 73.78B	kr 58.64B	kr 54.13B	kr 52.48B
Net Non Operating Interest Income Expense	kr -1.91B	kr 1.75B	kr -5.75B	kr -180.00M	kr -203.00M	kr -436.00M
Other Income Expense	kr -73.00M	kr -156.00M	kr -1.03B	kr 616.00M	kr -793.00M	kr -3.49B
Pretax Income	kr 70.39B	kr 104.67B	kr 69.06B	kr 59.08B	kr 53.13B	kr 48.55B
Tax Provision	kr 14.21B	kr 20.99B	kr 13.54B	kr 11.32B	kr 10.99B	kr 9.60B
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	kr 56.18B	kr 83.68B	kr 55.52B	kr 47.76B	kr 42.14B	kr 38.95B
Basic EPS	-	-	-	-	-	-
Diluted EPS	-	-	-	-	-	-
Basic Average Shares	-	-	-	-	-	-
Diluted Average Shares	-	-	-	-	-	-
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	kr 92.88B	kr 129.81B	kr 103.18B	kr 82.16B	kr 72.82B	kr 69.54B
Net Income From Continuing And Discontinued Operation	kr 56.18B	kr 83.68B	kr 55.52B	kr 47.76B	kr 42.14B	kr 38.95B
Normalized Income	kr 14.40B	-	-	kr 47.24B	kr 42.89B	kr 41.64B
Interest Expense	kr 3.73B	-	-	kr 289.00M	kr 390.00M	kr 220.00M
EBIT	kr 21.76B	-	-	kr 59.37B	kr 53.52B	kr 48.77B
EBITDA	kr 23.80B	-	-	kr 65.39B	kr 59.27B	kr 54.43B

Currency in DKK

Novo Nordisk Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing